Biotech Values

[zipjet]

Copaxone

My question is whether there is likely to be any causation related to the volume of the injection and the site injuries so common in Copaxone treated patients.

In fact, the opposite could turn out to be true, ie smaller volumes of higher concentration could cause more site damage.

I have no idea which might be true. But there is some inference supporting the former given that TEVA is reducing the volume.

ij